Cerevel Therapeutics Holdings, Inc.(CERE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CERE Cerevel Therapeutics Holdings, Inc.

盘前交易 07-22 08:07:24 EDT

42.90

+0.20

+0.47%

最高42.91	最低42.53	成交量224.16万
今开42.74	昨收42.70	日振幅0.89%
总市值78.16亿	流通市值33.39亿	总股本1.82亿
成交额9,576万	换手率2.88%	流通股本7,782万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CERE","market":"US","secType":"STK","nameCN":"Cerevel Therapeutics Holdings, Inc.","latestPrice":42.9,"timestamp":1721419200000,"preClose":42.7,"halted":0,"volume":2241590,"delay":0,"floatShares":77824202,"shares":182194722,"eps":-2.736044,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.2,"latestTime":"07-22 08:07:24 EDT","open":42.74,"high":42.91,"low":42.53,"amount":95760848.08745,"amplitude":0.008899,"askPrice":48.83,"askSize":100,"bidPrice":42.91,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-2.736044,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"adjPreClose":42.9,"postHourTrading":{"tag":"盘后","latestPrice":42.9,"preClose":42.9,"latestTime":"17:09 EDT","volume":78027,"amount":3347358.3,"timestamp":1721423364525},"volumeRatio":1.277127398693405,"impliedVol":0.4933,"impliedVolPercentile":0.628},"requestUrl":"/m/hq/s/CERE","defaultTab":"news","newsList":[{"id":"2446560609","title":"Cerevel Therapeutics Holdings, Inc.盘中异动 股价大涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446560609","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446560609?lang=zh_cn&edition=full","pubTime":"2024-06-28 03:42","pubTimestamp":1719517369,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日03时42分，Cerevel Therapeutics Holdings, Inc.股票出现异动，股价急速拉升7.21%。Cerevel Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Cerevel Therapeutics Holdings, Inc.公司简介：Cerevel Therapeutics Holdings Inc致力于揭示大脑的奥秘，以治疗神经科学疾病。Cerevel Therapeutics正在推进其当前的研发计划，同时通过内部研究工作，外部合作或潜在的收购来探索新的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628034249941f1ded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628034249941f1ded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERE","BK4139","LENZ"],"gpt_icon":0},{"id":"2446825825","title":"Cerevel Therapeutics Holdings, Inc.盘中异动 股价大跌5.02%报39.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446825825","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446825825?lang=zh_cn&edition=full","pubTime":"2024-06-25 23:36","pubTimestamp":1719329771,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日23时36分，Cerevel Therapeutics Holdings, Inc.股票出现波动，股价大幅跳水5.02%。Cerevel Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.98%。Cerevel Therapeutics Holdings, Inc.公司简介：Cerevel Therapeutics Holdings Inc致力于揭示大脑的奥秘，以治疗神经科学疾病。Cerevel Therapeutics正在推进其当前的研发计划，同时通过内部研究工作，外部合作或潜在的收购来探索新的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062523361196816ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062523361196816ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERE","BK4139"],"gpt_icon":0},{"id":"2431486898","title":"Cerevel Therapeutics Holdings Inc   预计每股亏损61美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431486898","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431486898?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:57","pubTimestamp":1714402677,"startTime":"0","endTime":"0","summary":"   * Cerevel Therapeutics Holdings Inc    将于5月1日公布截至2024年3月31日的财报() 预计该公司的季度收入将保持不变。*    * LSEG分析师对Cerevel Therapeutics Holdings Inc的平均预期是每股亏损61美分。* 华尔街对 Cerevel Therapeutics Holdings Inc 的 12 个月目标价中位数为 45.00 美元，高于其上次收盘价 42.47 美元。4月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CERE"],"gpt_icon":0},{"id":"2428084599","title":"艾伯维(ABBV.US)收购的Cerevel(CERE.US)达成帕金森病药物晚期阶段主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2428084599","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428084599?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:25","pubTimestamp":1713446711,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维的收购标的Cerevel Therapeutics周四宣布，其每日一次的帕金森病口服候选药物tavapadon在一项作为联合疗法的关键性三期试验中达成主要目标。Cerevel希望利用这些研究结果支持未来的他伐帕东监管申请。该候选药物在帕金森病中的两项后期单一疗法试验的顶线数据预计将于2024年下半年公布。去年12月，艾伯维同意以87亿美元收购Cerevel。据悉，艾伯维针对Cerevel的全现金收购预计将于2024年中期完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182128598b3637a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182128598b3637a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","LU1496350171.SGD","LU1551013342.USD","LU0708994859.HKD","BK4559","LU0198837287.USD","LU0122379950.USD","LU0795875169.SGD","IE00BFTCPJ56.SGD","LU0234572021.USD","LU0256863811.USD","LU1585245621.USD","LU0661504455.SGD","IE00BJT1NW94.SGD","LU1244550221.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU0820561818.USD","BK4566","LU1093756325.SGD","LU1732800096.USD","LU0310799852.SGD","IE0002141913.USD","LU0738911758.USD","BK4533","LU1023059063.AUD","LU0128525929.USD","LU1267930490.SGD","LU0943347566.SGD","BK4585","LU1732799900.SGD","LU1244550577.SGD","LU0689472784.USD","LU1057294990.SGD","IE0009355771.USD","LU0820561909.HKD","BK4550","LU0114720955.EUR","LU1291159041.SGD","LU0211327993.USD","LU1093756168.USD","LU0912757837.SGD","ABBV","LU0310800379.SGD","LU0882574055.USD","LU1267930573.SGD","CERE","LU0170899867.USD","LU0211328371.USD","IE0004445239.USD"],"gpt_icon":0},{"id":"2428859861","title":"BUZZ-帕金森病药物在后期试验中改善了症状控制，Cerevel 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2428859861","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428859861?lang=zh_cn&edition=full","pubTime":"2024-04-18 20:10","pubTimestamp":1713442227,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月18日 - ** 药物开发商Cerevel Therapeutics   股价盘前上涨1.4%至42.20美元** 该公司称 (link)，在一项后期研究中，其试验性帕金森病药物tavapadon作为左旋多巴（标准疗法）的附加疗法，改善了患者的症状控制。** CERE将在2024年下半年分享测试每日一次的tavapadon作为单一疗法的后期试验的其他数据。** 截至上次收盘，股价累计下跌 1.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","CERE","BK4139"],"gpt_icon":0},{"id":"2428364569","title":"Cerevel Therapeutics 公司的帕金森病药物在后期研究中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2428364569","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428364569?lang=zh_cn&edition=full","pubTime":"2024-04-18 18:37","pubTimestamp":1713436621,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月18日 - Cerevel Therapeutics   周四表示，其帕金森病药物达到了后期试验的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CERE","LENZ"],"gpt_icon":0},{"id":"2419983375","title":"BUZZ-穆迪称因GLP-1药物推动制药业前景转为 \"积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2419983375","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419983375?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:35","pubTimestamp":1710426957,"startTime":"0","endTime":"0","summary":"    3月14日 - ** 穆迪评级公司称，GLP-1 和其他大片药物已将美国制药业信贷展望从 \"稳定 \"提升至 \"积极\"。** 评级机构表示，该行业的增长将受益于大片药物使用量的增加，包括诺和诺德  和礼来  的GLP-1糖尿病和减肥治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU0672654240.SGD","MRK","LU0061475181.USD","LU2242646821.SGD","LU2125154778.USD","ABBV","LLY","IE00BLSP4452.SGD","SG9999001440.SGD","SG9999013999.USD","KRTX","LU1496350502.SGD","LU0738911758.USD","LU0965509283.SGD","LU0170899867.USD","SG9999001077.SGD","LU1430594728.SGD","LU1585245621.USD","LU0868494617.USD","LU0949170772.SGD","IE00BSNM7G36.USD","LU1718418525.SGD","LU2360032135.SGD","LU0109391861.USD","LU1670711040.USD","LU1988902786.USD","IE00BLSP4239.USD","LU0417517546.SGD","CERE","LU0861579265.USD","BK4139","LU2125154935.USD","GLP","BK4581","LU1291159041.SGD","MCO","SG9999014542.SGD","LU0708995401.HKD","LU1023059063.AUD","LU1814569148.SGD","BUZZ","LU1244550577.SGD","BMY","LU1064131342.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0661504455.SGD","BK4144","LU2106854487.HKD"],"gpt_icon":0},{"id":"2413288928","title":"据彭博社报道，艾伯维希望出售至少 130 亿美元债券为并购提供资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2413288928","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413288928?lang=zh_cn&edition=full","pubTime":"2024-02-22 07:03","pubTimestamp":1708556582,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社2月21日 - 彭博新闻社周三援引知情人士的话报道，艾伯维  正寻求出售至少130亿美元的公司债券，以帮助其为收购ImmunoGen和Cerevel Therapeutics  提供资金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU1244550577.SGD","LU0689472784.USD","BK4559","ABBV","LU1732799900.SGD","CERE","LU0234570918.USD","LU0949170772.SGD","BK4588","LU0128525929.USD","IE0004445239.USD","LU0456855351.SGD","LU1989772923.USD","IE00BJT1NW94.SGD","LU1496350502.SGD","LU0170899867.USD","LU1244550494.USD","BK4585","LU1839511570.USD","LU1023059063.AUD","BK4550","IE00B2B36J28.USD","LU0122379950.USD","BK4566","LU0738911758.USD","LU1057294990.SGD","LU1585245621.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0211327993.USD","LU1989771016.USD","LU1989772840.SGD","LU0661504455.SGD","IE0009355771.USD","LU0029864427.USD","LU0198837287.USD","LU1267930490.SGD","LU1732800096.USD","LU1718418525.SGD","BK4139","LU0158827948.USD","LU0234572021.USD","BK4581","LU0912757837.SGD","LU0795875086.SGD","LU1291159041.SGD","LU0820561818.USD","IE00BSNM7G36.USD","LU0708994859.HKD"],"gpt_icon":0},{"id":"2411668615","title":"Cerevel Therapeutics Holdings Inc   预计每股亏损59美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2411668615","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411668615?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:55","pubTimestamp":1708091721,"startTime":"0","endTime":"0","summary":"   * Cerevel Therapeutics Holdings Inc    将于2月20日公布截至2023年12月31日的财报() 预计该公司的季度收入将保持不变。*    * LSEG分析师对Cerevel Therapeutics Holdings Inc的平均预期为每股亏损59美分。* 华尔街对 Cerevel Therapeutics Holdings Inc 的 12 个月目标价中位数为 45.00 美元，高于其上次收盘价 42.93 美元。2月16日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cerevel.com","stockEarnings":[{"period":"1week","weight":0.0643},{"period":"1month","weight":0.0251},{"period":"3month","weight":0.0163},{"period":"6month","weight":0.0154},{"period":"1year","weight":0.4672},{"period":"ytd","weight":0.0118}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cerevel Therapeutics Holdings, Inc.是特拉华州的一家公司。该公司是一家临床阶段的生物制药公司，将对疾病相关生物学和大脑神经回路的深刻理解与先进的化学和中枢神经系统（中枢神经系统）靶向受体选择性药理学相结合，以发现和设计新的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087399},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01137},{"month":3,"riseRate":0.5,"avgChangeRate":0.043276},{"month":4,"riseRate":0.75,"avgChangeRate":0.024279},{"month":5,"riseRate":0.25,"avgChangeRate":-0.03235},{"month":6,"riseRate":0.75,"avgChangeRate":0.235861},{"month":7,"riseRate":0.25,"avgChangeRate":-0.008129},{"month":8,"riseRate":0.5,"avgChangeRate":0.028245},{"month":9,"riseRate":0,"avgChangeRate":-0.047536},{"month":10,"riseRate":0.5,"avgChangeRate":0.109092},{"month":11,"riseRate":0.75,"avgChangeRate":0.067582},{"month":12,"riseRate":1,"avgChangeRate":0.234479}],"exchange":"NASDAQ","name":"Cerevel Therapeutics Holdings, Inc.","nameEN":"Cerevel Therapeutics Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cerevel Therapeutics Holdings, Inc.(CERE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cerevel Therapeutics Holdings, Inc.(CERE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cerevel Therapeutics Holdings, Inc.,CERE,Cerevel Therapeutics Holdings, Inc.股票,Cerevel Therapeutics Holdings, Inc.股票老虎,Cerevel Therapeutics Holdings, Inc.股票老虎国际,Cerevel Therapeutics Holdings, Inc.行情,Cerevel Therapeutics Holdings, Inc.股票行情,Cerevel Therapeutics Holdings, Inc.股价,Cerevel Therapeutics Holdings, Inc.股市,Cerevel Therapeutics Holdings, Inc.股票价格,Cerevel Therapeutics Holdings, Inc.股票交易,Cerevel Therapeutics Holdings, Inc.股票购买,Cerevel Therapeutics Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cerevel Therapeutics Holdings, Inc.(CERE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cerevel Therapeutics Holdings, Inc.(CERE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}